Strikingly, the expression of classical breast cancer subtype markers ER and PR were reduced to near undetectable levels while HER2 was reduced 64-fold and Ki-67 mRNA was increased 4-fold (Fig. 2A). This evidence concerns the gene ERBB2 and breast cancer.